Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review

October 2021 | 51 pages | ID: AFA07A0F6BBEN
GlobalData

Abstracts

Anika Therapeutics Inc (ANIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include human and veterinary visco-supplementation, Joint implant, instrumentation devices, joint replacement solutions, regenerative and orthopedic surgical therapies, bone repair therapy, advanced wound care and ophthalmic products. Its products are made from hyaluronic acid (HA) based on technology, HYAFF, which is a solid form of HA. Anika has research and manufacturing facilities in Bedford, Massachusetts. The company offers products through distributors in the Latin America, Canada, Europe, the Middle East, and Asia. Anika is headquartered in Massachusetts, the US.

Anika Therapeutics Inc Key Recent Developments

Oct 18,2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
Sep 07,2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Jul 19,2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
May 13,2021: Anika to Host its 2021 Virtual Investor Day on June 3, 2021
May 06,2021: Anika Reports First Quarter 2021 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Anika Therapeutics Inc - Key Facts
Anika Therapeutics Inc - Key Employees
Anika Therapeutics Inc - Key Employee Biographies
Anika Therapeutics Inc - Major Products and Services
Anika Therapeutics Inc - History
Anika Therapeutics Inc - Company Statement
Anika Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Anika Therapeutics Inc - Business Description
Product Category: Joint Pain Management Therapies
Overview
Performance
Product Category: Orthopedic Joint Preservation and Restoration Care
Overview
Performance
Product Category: Other Products
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Other
Target Markets
Performance
Geographical Segment: US
Performance
Anika Therapeutics Inc - Corporate Strategy
Anika Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Anika Therapeutics Inc - Strengths
Anika Therapeutics Inc - Weaknesses
Anika Therapeutics Inc - Opportunities
Anika Therapeutics Inc - Threats
Anika Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anika Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
May 13, 2021: Anika to Host its 2021 Virtual Investor Day on June 3, 2021
May 06, 2021: Anika Reports First Quarter 2021 Financial Results
Apr 05, 2021: Anika to Participate in the 20th Annual Needham Virtual Healthcare Conference
Mar 11, 2021: Anika to Participate in the Sidoti Spring Virtual Investor Conference
Mar 04, 2021: Anika Reports Fourth Quarter and Year-End 2020 Financial Results
Nov 04, 2020: Anika reports third-quarter 2020 financial results
Sep 08, 2020: Anika announces appointment of Jack Henneman and Stephen Richard to board of directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Anika Therapeutics Inc, Key Facts
Anika Therapeutics Inc, Key Employees
Anika Therapeutics Inc, Key Employee Biographies
Anika Therapeutics Inc, Major Products and Services
Anika Therapeutics Inc, History
Anika Therapeutics Inc, Subsidiaries
Anika Therapeutics Inc, Key Competitors
Anika Therapeutics Inc, Ratios based on current share price
Anika Therapeutics Inc, Annual Ratios
Anika Therapeutics Inc, Annual Ratios (Cont...1)
Anika Therapeutics Inc, Annual Ratios (Cont...2)
Anika Therapeutics Inc, Interim Ratios
Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anika Therapeutics Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Anika Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Anika Therapeutics Inc, Performance Chart (2016 - 2020)
Anika Therapeutics Inc, Ratio Charts
Anika Therapeutics Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Anika Therapeutics Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021